CTYNasdaqPharmaceutical PreparationsFiscal year ends December 31
CITY THERAPEUTICS, INC.
$21.46−0.94 (-4.20%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns City Therapeutics's shares
No ownership filings found
No 13F institutional holdings, fund holdings or insider filings (Forms 3, 4 and 5) are on record for CTY.